Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
97.20    -0.70 (-0.72%)
Bid:
97.20
Ask:
98.20
Spread: 1.00 (1.029%)
Market Cap: £591.16m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Directors' dealing

22 Dec 2016 16:54

Syncona Limited - Directors' dealing

Syncona Limited - Directors' dealing

PR Newswire

London, December 22

Syncona Limited

(the “Company”)

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

22 December 2016 

1.Details of PDMR / person closely associated with them ("PCA")
a)NameJeremy Tigue
b)Position / statusNon-Executive Director
c)Initial notification / amendmentInitial Notification
2.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrumentOrdinary shares 
b)Nature of the transactionPurchase of shares
c)Price(s) and volume(s)Price(s)Volume(s)
£1.3115112,154
d)Aggregated information Aggregated volume Price N/A
e)Date of the transaction19 December 2016
f)Place of the transactionLondon Stock Exchange

 

1.Details of PDMR / person closely associated with them ("PCA")
a)NamePeter Hames
b)Position / statusNon-Executive Director
c)Initial notification / amendmentInitial Notification
2.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrumentOrdinary shares 
b)Nature of the transactionPurchase of shares
c)Price(s) and volume(s)Price(s)Volume(s)
£1.311522,430
d)Aggregated information Aggregated volume Price N/A
e)Date of the transaction19 December 2016
f)Place of the transactionLondon Stock Exchange

1.Details of PDMR / person closely associated with them ("PCA")
a)NameThomas Henderson
b)Position / statusNon-Executive Director
c)Initial notification / amendmentInitial Notification
2.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrumentOrdinary shares 
b)Nature of the transactionPurchase of shares
c)Price(s) and volume(s)Price(s)Volume(s)
£1.3115300,000
d)Aggregated information Aggregated volume Price N/A
e)Date of the transaction19 December 2016
f)Place of the transactionLondon Stock Exchange

1.Details of PDMR / person closely associated with them ("PCA")
a)NameNicholas Moss
b)Position / statusNon-Executive Director
c)Initial notification / amendmentInitial Notification
2.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrumentOrdinary shares 
b)Nature of the transactionPurchase of shares
c)Price(s) and volume(s)Price(s)Volume(s)
£1.31154,822
d)Aggregated information Aggregated volume Price N/A
e)Date of the transaction19 December 2016
f)Place of the transactionLondon Stock Exchange

EnquiriesCompany SecretaryNorthern Trust International Fund Administration Services (Guernsey) LimitedPO Box 255, Trafalgar CourtLes BanquesSt Peter PortGuernseyGY1 3QL +44 (0)1481 745001 

Date   Source Headline
17th May 202412:05 pmRNSAutolus reports Q1 2024 Financial Results
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares
9th May 202411:05 amRNSFreeline presents clinical data update
9th May 20247:00 amRNSTransaction in Own Shares
8th May 202412:11 pmRNSAchilles reports Q1 2024 Financial Results
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20242:14 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202412:02 pmRNSCentury Therapeutics to acquire Clade Therapeutics
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 202411:50 amRNSAchilles reports full year 2023 Financial Results
4th Apr 202411:47 amRNSAchilles provides clinical data update
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20242:45 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.